SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001308179-20-000229
Filing Date
2020-04-28
Accepted
2020-04-28 16:06:21
Documents
60
Period of Report
2020-06-03
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC - DEF 14A lvrtx2020_def14a.htm DEF 14A 1160314
2 GRAPHIC bullet.jpg GRAPHIC 783
3 GRAPHIC lvrtx_proxy1.jpg GRAPHIC 291615
4 GRAPHIC lvrtx_proxy2.jpg GRAPHIC 372169
5 GRAPHIC lvrtx3x2.jpg GRAPHIC 4574
6 GRAPHIC lvrtxx1x1.jpg GRAPHIC 1312
7 GRAPHIC lvrtxx1x2.jpg GRAPHIC 1021
8 GRAPHIC lvrtxx1x3.jpg GRAPHIC 7743
9 GRAPHIC lvrtxx2x1.jpg GRAPHIC 531118
10 GRAPHIC lvrtxx4x1.jpg GRAPHIC 7105
11 GRAPHIC lvrtxx5x1.jpg GRAPHIC 5615
12 GRAPHIC lvrtxx5x2.jpg GRAPHIC 3627
13 GRAPHIC lvrtxx6x1.jpg GRAPHIC 6848
14 GRAPHIC lvrtxx7x1.jpg GRAPHIC 6857
15 GRAPHIC lvrtxx8x1.jpg GRAPHIC 88300
16 GRAPHIC lvrtxx9x1.jpg GRAPHIC 68645
17 GRAPHIC lvrtxx10x1.jpg GRAPHIC 143300
18 GRAPHIC lvrtxx11x1.jpg GRAPHIC 110242
19 GRAPHIC lvrtxx12x1.jpg GRAPHIC 39672
20 GRAPHIC lvrtxx12x2.jpg GRAPHIC 4127
21 GRAPHIC lvrtxx12x3.jpg GRAPHIC 4299
22 GRAPHIC lvrtxx12x4.jpg GRAPHIC 4281
23 GRAPHIC lvrtxx12x5.jpg GRAPHIC 870
24 GRAPHIC lvrtxx12x6.jpg GRAPHIC 872
25 GRAPHIC lvrtxx12x7.jpg GRAPHIC 967
26 GRAPHIC lvrtxx12x8.jpg GRAPHIC 970
27 GRAPHIC lvrtxx15x1.jpg GRAPHIC 143509
28 GRAPHIC lvrtxx19x1.jpg GRAPHIC 2402
29 GRAPHIC lvrtxx19x2.jpg GRAPHIC 2384
30 GRAPHIC lvrtxx19x3.jpg GRAPHIC 2472
31 GRAPHIC lvrtxx19x4.jpg GRAPHIC 2921
32 GRAPHIC lvrtxx19x5.jpg GRAPHIC 4309
33 GRAPHIC lvrtxx19x6.jpg GRAPHIC 1620
34 GRAPHIC lvrtxx19x7.jpg GRAPHIC 2437
35 GRAPHIC lvrtxx19x8.jpg GRAPHIC 2907
36 GRAPHIC lvrtxx19x9.jpg GRAPHIC 3144
37 GRAPHIC lvrtxx19x10.jpg GRAPHIC 2520
38 GRAPHIC lvrtxx19x11.jpg GRAPHIC 90409
39 GRAPHIC lvrtxx27x1.jpg GRAPHIC 1003
40 GRAPHIC lvrtxx27x2.jpg GRAPHIC 1042
41 GRAPHIC lvrtxx27x3.jpg GRAPHIC 1064
42 GRAPHIC lvrtxx27x4.jpg GRAPHIC 1041
43 GRAPHIC lvrtxx27x5.jpg GRAPHIC 923
44 GRAPHIC lvrtxx32x1.jpg GRAPHIC 5348
45 GRAPHIC lvrtxx32x2.jpg GRAPHIC 5533
46 GRAPHIC lvrtxx32x3.jpg GRAPHIC 73984
47 GRAPHIC lvrtxx33x1.jpg GRAPHIC 5441
48 GRAPHIC lvrtxx41x1.jpg GRAPHIC 95537
49 GRAPHIC lvrtxx42x1.jpg GRAPHIC 67374
50 GRAPHIC lvrtxx43x1.jpg GRAPHIC 203775
51 GRAPHIC lvrtxx44x1.jpg GRAPHIC 149770
52 GRAPHIC lvrtxx44x2.jpg GRAPHIC 27988
53 GRAPHIC lvrtxx45x1.jpg GRAPHIC 58530
54 GRAPHIC lvrtxx45x2.jpg GRAPHIC 157001
55 GRAPHIC lvrtxx50x1.jpg GRAPHIC 70267
56 GRAPHIC lvrtxx50x2.jpg GRAPHIC 60419
57 GRAPHIC lvrtxx55x1.jpg GRAPHIC 102947
58 GRAPHIC lvrtxx89x1.jpg GRAPHIC 370545
59 GRAPHIC tick.jpg GRAPHIC 1094
60 GRAPHIC tick1.jpg GRAPHIC 1089
  Complete submission text file 0001308179-20-000229.txt   5892963
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 20825001
SIC: 2834 Pharmaceutical Preparations